Posts Tagged ‘Virgo’

The elephant in the ‘breakfast’ room

Friday, February 3rd, 2012

This week saw the launch of the Government’s first ever national campaign to raise awareness of the signs of bowel cancer. ‘Be Clear on Cancer’ encourages those with persistent symptoms to present promptly to catch the tumour earlier, with an ultimate aim of improving survival rates across the UK.

In spite of the condition being the third most common cancer across the country, to date there’s been clear reluctance to focus the public spotlight on it. Be Clear on Cancer has of course been backed by leading charities, such as Beating Bowel Cancer and Bowel Cancer UK, both of which provide exceptional ongoing support to patients and their families.

The launch of the initiative has received extensive press interest but the way in which it’s been welcomed by the media is somewhat ironic. Despite the whole point of the campaign being to raise awareness of the symptoms of the condition, it seems a proportion of editors have shied away from the nitty gritty ‘below-the-belt’ symptoms and left key campaign messages out of their reporting. We do appreciate it’s not exactly what you want to hear blaring out of the radio during your morning ablutions or digest while eating your bowl of cornflakes. However the media are such a powerful communications vehicle, and in this day and age there must be a more palatable way in which to educate the public via these still important traditional routes so that we can talk more frankly and hinder the number of cases soaring?

There’s a raft of disease areas where Pharma, healthcare professionals and charities can really collaborate with the media and work together on the best means to communicate to the masses/stimulate discussion that suffer the same taboo, and each deserve the appropriate air time!

In the meantime, on behalf of all those supporting #BeClearOnCancer, the initial symptoms of bowel cancer include:

  • blood in your stools
  • a change to your normal bowel habits that persists for more than six weeks
  • abdominal pain and/or unexplained weight loss

Embarrassed? Uncomfortable? You shouldn’t be.

Pharmerging markets: emerging opportunities for healthcare communications?

Wednesday, January 25th, 2012

Last year, investment in emerging markets within the pharmaceutical industry continued apace, with increased revenues and strong sales seen in India, China, Brazil and Russia. This trend is expected to continue, as recently forecast by IMS Health. Moreover, over the next five years emerging markets are expected to double their spending on medicines. As highlighted previously, market demand for more effective products and widening healthcare access due to increasing generic penetration will be among the major contributors driving growth in the ‘pharmerging’ markets. In contrast, European and US spending on pharmaceutical products is set to decline over the same period from 24 per cent to 19 per cent and from 36 per cent to 31 per cent respectively. But what do these contrasting growth stories mean for the healthcare communications industry and can the global market adapt to this flux to leverage growth in the US and UK?

Historically, it was the introduction of blockbuster drugs that put the western world at the forefront of the global pharmaceutical market, leading the way in innovation and research. Meanwhile, replicating generic versions of these drugs defined the pharma industry in the developing markets. Today however, the established markets are faced with record patent expirations, a lack of new generation blockbuster medicines despite investment in clinical trials, and ongoing regulatory challenges against an already challenging economic backdrop. In pharmerging markets, rapid growth has been principally generated by spending on generic drugs, contributing to the rise in the generic share of spending.

Success in LEDCs (less economically developed countries) has understandably tempted western companies to look further afield to tap into the opportunities within the generics market, with some companies already involved in full or partial takeover bids in these increasingly influential emerging markets. As well as allowing the integration of the western industry, these acquisitions will undoubtedly provide benefits for the drugmaker concerned, potentially creating a positive feedback loop within the developing economy and exposing important insights to inform global communications and marketing programmes.

Taking a closer look, the lack of breakthrough drugs may not be as much of a concern as it first appears. The expected shift towards personalised medicine could mean a diminishing reliance on the ‘one pill fits all’ model. Whilst the increasing availability of genetic information could also see the reappraisal of certain compounds that previously struggled economically in the blockbuster era. What is absolutely certain from these unfolding changes, is that the healthcare communications industry will play an ever more critical role in explaining these emerging opportunities to both patients and all concerned stakeholders, ultimately ensuring patient needs remain the priority and at the heart of all communications programmes.

The meaning of colour – so what for Pharma?

Thursday, January 19th, 2012

PANTONE® has recently announced PANTONE® 17-1463 Tangerine Tango, a dramatic reddish orange, as 2012’s colour of the year.

According to Leatrice Eiseman, executive director of the Pantone Colour Institute®, “Tangerine Tango combines the vivaciousness and adrenaline rush of red with the friendliness and warmth of yellow, to form a high-visibility, magnetic hue that emanates heat and energy”.

What does Tangerine Tango mean to you? A single colour has the ability to evoke all of the senses, creating a wealth of thoughts, feelings and visions in the mind of the viewer in seconds. Colour is therefore the mainstay of design across a range of industries, the pharmaceutical industry included.

Communication and marketing within the pharmaceutical industry is more important today than it has ever been and colour is an essential component of brand development and campaign identity.  Think pink and breast cancer immediately springs to mind; think blue think Viagra, and so on…  consider whether tranquil blue or fiery red represent a good night’s sleep and the answer is immediately obvious.

Consequently, pharmaceutical companies are continuing to invest in ever more daring design options to support and enhance their brands.  So, with over 13,500 PANTONE® colours to choose from, which will be critical to the pharmaceutical industry’s next blockbuster brand?  Tangerine Tango perhaps?

Source: www.Pantone.com

2012: What changes can we expect in the NHS?

Thursday, January 12th, 2012

Like a late Christmas present, this week the NHS Future Forum published its report with recommendations on four key issues within the NHS: integration, public health, information and education. Most striking was the proposal that HCPs should make ‘every contact count’ by questioning patient lifestyle choices at every opportunity.

The Government’s response has been to fully accept the report’s suggestions, as many tie in with the general programme of reforms set out in the Health and Social Care Bill. However, much like many of the proposals we saw outlined in the Bill and put into practice over the past year, other groups have been less enthusiastic. For example, Dr Clare Gerada, chair of the RCGP, has voiced concerns at the lack of evidence base for public health proposals, and that questioning patients at every opportunity may even be detrimental to the patient/physician relationship.

This is the first report of what will likely be many throughout 2012 both supporting reform and condemning it in equal measure. But what changes within the NHS can be expected in the coming year? Here are a few points that the Virgo HEALTH team will be looking out for…

First and foremost, the Health and Social Care Bill will receive Royal Assent, with most proposals likely to be still intact. Even so, there are lingering questions over Andrew Lansley’s position within the Cabinet. Will he continue to serve as Secretary of State into 2013? In all likelihood, yes – but nothing is certain.
As the Government progresses with the reforms throughout 2012, we will see the further dismantlement of current NHS structures and consolidation of new bodies such as the NHS Commissioning Board and Clinical Commissioning Groups in their place. However, there will continue to be plenty of debate over the composition and size of these groups, and the role traditional commissioners from PCT and SHA backgrounds can play in them. 2012 should therefore provide more answers as to the future these managers have within the new NHS.

The DH published figures at the end of December confirming that it was on track to deliver the savings required for the year 2011/12 as set out in the Budget, recording savings of £2.5 billion in the first 6 months of the efficiency challenge. Many argue that the easy cuts have been already been made, and that the NHS will be facing an increasingly difficult challenge to try and find further savings. We will see whether the figure of £6 billion for the year is achieved in the summer, and towards the end of the year, whether it is still on track to hit its final target.

Finally, ‘no decision about me, without me’ as an underpinning principle behind the reforms will begin to come to the fore. Can we expect to see patients taking more interest in their care, as more choice is provided, and information becomes available? Andrew Lansley has stated this week that ‘blacklisting’ of NHS drugs needs to be ended to stop the current ‘postcode lottery’, but also to avoid the threat of legal action from patients who know their rights.

We are sure you will be following developments in the NHS like us, during a year which will undoubtedly be crucial for the success of the reforms and economic future of the NHS.

Why privacy issues won’t put people off Facebook

Friday, July 30th, 2010

The author of a report which features the personal details of 100 million Facebook users says he released the information to highlight the privacy issues associated with social networking. This has received widespread media pick-up because it is captivating, and a classic attention-grabbing scare story. But it is not the massive scandal it might appear to be. People who don’t want to share their personal lives online don’t. And people who are happy to be open about their information online aren’t going to stop using social networks just because of this report. Facebook scare stories are nothing new (as we said in a post not long ago). So is this a complete red herring? Should we care in the field of healthcare communications?
(more…)

In defence of healthcare communications

Monday, July 19th, 2010

Our blog post last week ‘NHS White Paper: What the patient-centric approach means for healthcare communications’ ignited some debate on Twitter which we want to respond to. You can see the tweets people sent about the post on the page itself and our thoughts on these below.
(more…)

2010 Communiqué awards: A reminder of the impact and potential healthcare comms can have

Tuesday, July 13th, 2010

Never has the saying ‘perception is reality’ been more true for healthcare communications than it is today, particularly given the publication of the NHS White Paper and its focus on outcomes and choice for all. Everyone is a potential stakeholder and the stakes are high. Each year the Communiqué awards commend excellence and best practice and we are reminded how healthcare communications can meet these challenges and deliver real improvements in healthcare information dissemination, provision and choice.
  (more…)

We’re becoming an ‘appy nation

Thursday, July 1st, 2010

It seems that no business is truly innovative unless they have a novel way of reaching out to their customers. Recently, Apple’s iPhone applications have opened up a new world of reference tools, games and ways to interact with each other. However, apps in the health space are a more exciting and potentially life saving prospect with medical reference guides, diagnosis tools and live GP consultations (coming to an iPhone near you soon).

(more…)

Virgo HEALTH sets record straight on BBC Watchdog exposé of Virgo Healthcare

Friday, June 11th, 2010

Last night BBC Watchdog exposed the shocking conduct of ‘Rogue Trader’ Virgo Healthcare, a company scamming vulnerable elderly people to buy mobility equipment, a company Virgo HEALTH (we, the good guys) are in no way associated with. It’s odd hearing your name on TV, especially in such a damning report. Jaws dropped and then the phones started ringing. Quite quickly we realised we had to put a plan in place…

(more…)

Virgo HEALTH is NOT Virgo Healthcare Nottingham featured on Watchdog

Thursday, June 10th, 2010

Virgo HEALTH is a reputable and highly respected communications consultancy based in Richmond, Surrey and is in no way associated with the company Virgo Healthcare recently featured on BBC Watchdog! We are as shocked and appalled as everyone else at the way the Virgo Healthcare featured on Watchdog has conducted its business. We are happy to assist in redirecting any calls we receive to Derbyshire Police who are now investigating. For any enquiries please contact us at info@virgohealth.com